Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction

Editorial Comments

Anthony Atala

Research output: Contribution to journalArticle

Original languageEnglish
JournalJournal of Urology
Volume186
Issue number1
DOIs
StatePublished - Jul 1 2011

Fingerprint

Doxorubicin
Prostatic Neoplasms
Sildenafil Citrate

ASJC Scopus subject areas

  • Urology

Cite this

Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction : Editorial Comments. / Atala, Anthony.

In: Journal of Urology, Vol. 186, No. 1, 01.07.2011.

Research output: Contribution to journalArticle

@article{0653abc5c0744e13b160477aa8cf5d94,
title = "Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction: Editorial Comments",
author = "Anthony Atala",
year = "2011",
month = "7",
day = "1",
doi = "10.1016/j.juro.2011.03.076",
language = "English",
volume = "186",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction

T2 - Editorial Comments

AU - Atala, Anthony

PY - 2011/7/1

Y1 - 2011/7/1

UR - http://www.scopus.com/inward/record.url?scp=79958281136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958281136&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2011.03.076

DO - 10.1016/j.juro.2011.03.076

M3 - Article

VL - 186

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 1

ER -